<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00588562</url>
  </required_header>
  <id_info>
    <org_study_id>11-001702</org_study_id>
    <secondary_id>1U54DK083908-01</secondary_id>
    <nct_id>NCT00588562</nct_id>
  </id_info>
  <brief_title>Rare Kidney Stone Consortium Patient Registry</brief_title>
  <acronym>RKSC</acronym>
  <official_title>Rare Kidney Stone Consortium Registry for Hereditary Kidney Stone Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oxalosis and Hyperoxaluria Foundation (OHF)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect medical information from a large number of patients
      in many areas of the world with primary hyperoxaluria (PH), Dent disease, Cystinuria and APRT
      deficiency. This information will create a registry that will help us to compare similarities
      and differences in patients and their symptoms. The more patients we are able to enter into
      the registry, the more we will be able to understand the Primary Hyperoxalurias,Dent disease,
      cystinuria and APRT and learn better ways of caring for patients with these diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study involves the collection of medical information to create a computer database or
      registry for patients with PH, Dent disease, cystinuria and APRT deficiency. The information
      will be entered into the registry by your physician or health care provider. The computer web
      site for the registry is secure and protected by a required password. Some information which
      will be entered may include your age at first symptoms of PH,Dent disease, cystinuria or
      APRT, laboratory values, kidney function and the progress of your health over time.
      Information for an individual patient can only be viewed by the appropriate physician or
      staff. Once the information is entered into the registry, you will only be identified by a
      code number.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2003</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Establish and expand registries and collaborate with patient organizations for the rapid dissemination of knowledge</measure>
    <time_frame>Yearly</time_frame>
    <description>The patient Registries will expand knowledge of the clinical expression of these disease by systematically accumulating and analyzing information regarding a larger number of patients than have been studied to date.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improved understanding of symptoms and progression of four major diseases of hereditary nephrolithiasis.</measure>
    <time_frame>Yearly</time_frame>
    <description>The goal of the patient Registries is to collect data about these rare diseases, provide a better understanding of these four conditions and help to develop new treatments.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">730</enrollment>
  <condition>Primary Hyperoxaluria</condition>
  <condition>Dent Disease</condition>
  <condition>Cystinuria</condition>
  <condition>APRT Deficiency</condition>
  <arm_group>
    <arm_group_label>Primary Hyperoxaluria patients</arm_group_label>
    <description>Registry will include data on patients with confirmed diagnosis of Primary Hyperoxaluria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dent Disease Patients</arm_group_label>
    <description>Registry will include data on patients with confirmed diagnosis of Dent Disease.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cystinuria Patients</arm_group_label>
    <description>Registry will include data on patients with confirmed diagnosis of Cystinuria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>APRT deficiency Patients</arm_group_label>
    <description>Registry will include data on patients with confirmed diagnosis of APRT deficiency.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals with Primary Hyperoxaluria, Dent Disease, Cystinuria and APRT Deficiency.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals must have a definitive diagnosis of Primary Hyperoxaluria, Dent Disease,
             Cystinuria or APRT Deficiency.

          -  Individuals have a family history of a sibling with Primary Hyperoxaluria,Dent
             Disease, Cystinuria or APRT Deficiency.

        Exclusion Criteria:

          -  Individuals who do not have Primary Hyperoxaluria, Dent Disease, Cystinuria or APRT
             Deficiency.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dawn S. Milliner, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Primary Hyperoxaluria Registry - Mayo Clinic, Rochester, MN</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Goldfarb, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cystinuria Registry, New York University, NY</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John C Lieske, MD</last_name>
    <role>Study Director</role>
    <affiliation>Dent Disease Registry, Mayo Clinic, Rochester, MN</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vidar Edvardsson, MD</last_name>
    <role>Study Director</role>
    <affiliation>APRT Registry, Landspitali University Hospital, Iceland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julie B. Olson, RN</last_name>
    <phone>507-538-5995</phone>
    <email>rarekidneystones@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mayo Clinic Hyperoxaluria Center</last_name>
    <phone>1-800-270-4637</phone>
    <email>hyperoxaluriacenter@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dent Disease Registry -Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barb M Seide, Study Coord</last_name>
      <phone>800-270-4637</phone>
      <email>rarekidneystones@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Julie B Olson, RN Coord</last_name>
      <phone>800-270-4637</phone>
      <email>rarekidneystones@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>John C Lieske, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Primary Hyperoxaluria Registry - Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barb M Seide, Study Coord</last_name>
      <phone>800-270-4637</phone>
      <email>hyperoxaluriacenter@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Julie B Olson, RN Coord</last_name>
      <phone>800-270-4637</phone>
      <email>hyperoxaluriacenter@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Dawn S. Milliner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cystinuria Registry - New York University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Goldfarb, MD</last_name>
      <phone>212-263-0744</phone>
      <email>David.Goldfarb@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Frank Modersitzki, MPH</last_name>
      <phone>216-686-7500</phone>
      <phone_ext>6379</phone_ext>
      <email>Frank.Modersitzki@nyumc.org</email>
    </contact_backup>
    <investigator>
      <last_name>David Goldfarb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>APRT Registry - Landspitali Universtiy Hospital</name>
      <address>
        <city>Reykjavik</city>
        <country>Iceland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vidar Edvardsson, MD</last_name>
      <phone>354-824-5227</phone>
      <email>vidare@landspitali.is</email>
    </contact>
    <contact_backup>
      <last_name>Runolfur Palsson, MD</last_name>
      <phone>354-824-5227</phone>
      <email>runolfur@landspitali.is</email>
    </contact_backup>
    <investigator>
      <last_name>Vidar Edvardsson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iceland</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mayoclinic.org/nephrology-rst/hyperoxaluriacenter.html</url>
    <description>Mayo Clinic Hyperoxaluria Center</description>
  </link>
  <link>
    <url>http://clinicaltrials.mayo.edu</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2007</study_first_submitted>
  <study_first_submitted_qc>December 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2008</study_first_posted>
  <last_update_submitted>August 3, 2017</last_update_submitted>
  <last_update_submitted_qc>August 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Dawn S. Milliner, M.D.</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>PH</keyword>
  <keyword>PH1</keyword>
  <keyword>PH2</keyword>
  <keyword>PH3</keyword>
  <keyword>PHI</keyword>
  <keyword>PHII</keyword>
  <keyword>PHIII</keyword>
  <keyword>PH NonI-NonII</keyword>
  <keyword>Primary Hyperoxaluria</keyword>
  <keyword>Primary Oxalosis</keyword>
  <keyword>Hyperoxaluria</keyword>
  <keyword>Oxalate</keyword>
  <keyword>Cystinuria</keyword>
  <keyword>Cystine</keyword>
  <keyword>APRT</keyword>
  <keyword>Adenine phosphoribosyl transferase deficiency</keyword>
  <keyword>Dent disease</keyword>
  <keyword>Dent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Hyperoxaluria, Primary</mesh_term>
    <mesh_term>Cystinuria</mesh_term>
    <mesh_term>Dent Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Using limited data set, data will be shared through the Data Monitoring and Coordinating Center of the Rare Diseases Clinical Research Network.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

